F-star Therapeutics Appoints James Sandy as Chief Development Officer

Go back to F-star Therapeutics Appoints James Sandy as Chief Development Officer
(NASDAQ: FSTX) Delayed: 7.12 --0 (-0%)
Previous Close $7.12    52 Week High $ 
Open $12.36    52 Week Low $ 
Day High $7.12    P/E N/A 
Day Low $7.12    EPS $ 
Volume 1,067,673       

(NASDAQ: IMCR) Delayed: 29.40 -0.08 (0.27%)
Previous Close $29.48    52 Week High $ 
Open $29.53    52 Week Low $ 
Day High $30.17    P/E N/A 
Day Low $28.62    EPS $ 
Volume 924,940